J Korean Diabetes.  2021 Sep;22(3):192-196. 10.4093/jkd.2021.22.3.192.

Psychological Insulin Resistance: Key Factors and Intervention

• Jang YJ

• KMID: 2526200
• DOI: http://doi.org/10.4093/jkd.2021.22.3.192

Abstract

Insulin is a mainstay of treatment in patients with type 2 diabetes mellitus to control blood sugar levels and reduce the risk of diabetes complications, but psychological insulin resistance can delay insulin treatment. Psychological insulin resistance can be defined as a negative attitude and feelings toward insulin treatment experienced by diabetics. Factors influencing psychological insulin resistance include a lack of understanding of diabetic pathophysiology, a negative attitude toward insulin treatment, anxiety about insulin therapy complications and hypoglycemia, distorted beliefs, daily constraints, fear or pain from injections, and discomfort. Various approaches to psychological insulin resistance involve direct demonstration of the insulin administration processes, education regarding diabetic pathophysiology and insulin action, assessment and evaluation of the degree of psychological insulin resistance, patient group training, building correct support systems, and providing contacts (e.g., diabetes center, diabetes nurse educator). The role of healthcare providers is important in reducing patients’ psychological insulin resistance through various interventions.

Keyword

Diabetes mellitus; type 2; Insulin; Psychology; Psychological intervention

Reference

1. Korean Diabetes Association. Diabetes fact sheet 2020. Seoul: Korean Diabetes Association;2020. p. 6–16.

2. Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu JY, Huang ES, et al. The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (the diabetes & aging study). Diabetes Care. 2019; 42:416–26.

3. Korean Diabetes Association. Treatment guideline for diabetes. 6th ed.Seoul: Gold's Planning and Development;2019. p. 69.

4. Hong SH, Kim MJ, Noh SG, Suh DW, Youn SJ, Lee KW, et al. A study on resistance in type 2 diabetic patient against commencement of insulin treatment. Korean Diabetes J. 2008; 32:269–79.

5. Hosomura N, Malmasi S, Timerman D, Lei VJ, Zhang H, Chang L, et al. Decline of insulin therapy and delays in insulin initiation in people with uncontrolled diabetes mellitus. Diabet Med. 2017; 34:1599–602.

6. Song Y. Concept analysis for psychological insulin resistance in Korean people with diabetes. J Korean Acad Nurs. 2016; 46:443–53.

7. Brod M, Kongs⊘ JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009; 18:23–32.

8. Gherman A, Veresiu IA, Sassu RA, Schnur JB, Scheckner BL, Montgomery GH. Psychological insulin resistance: a critical review of the literature. Pract Diabetes Int. 2019; 28:125–8.

9. Karter AJ, Subramanian U, Saha C, Crosson JC, Parker MM, Swain BE, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010; 33:733–5.

10. Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med. 2012; 29:682–9.

11. Holmes-Truscott E, Skinner TC, Pouwer F, Speight J. Negative appraisals of insulin therapy are common among adults with Type 2 diabetes using insulin: results from Diabetes MILES - Australia cross-sectional survey. Diabet Med. 2015; 32:1297–303.

12. Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, et al. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ. 2008; 34:511–7.

13. Makine C, Karşidağ C, Kadioğlu P, Ilkova H, Karşidağ K, Skovlund SE, et al. Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naïve patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium. Diabet Med. 2009; 26:28–33.

14. Polonsky WH, Hajos TR, Dain MP, Snoek FJ. Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population. Curr Med Res Opin. 2011; 27:1169–74.

15. Song Y, Jeon Y, Cho J, Kim B. Development of a psychological insulin resistance scale for Korean patients with diabetes. J Korean Acad Nurs. 2016; 46:813–23.

16. Polonsky WH, Fisher L, Hessler D, Stuckey H, Snoek FJ, Tang T, et al. Identifying solutions to psychological insulin resistance: an international study. J Diabetes Complications. 2019; 33:307–14.

17. Okazaki K, Shingaki T, Cai Z, Perez-Nieves M, Fisher L. Successful healthcare provider strategies to overcome psychological insulin resistance in Japanese patients with type 2 diabetes. Diabetes Ther. 2019; 10:1823–34.

18. Stuckey H, Fisher L, Polonsky WH, Hessler D, Snoek FJ, Tang TS, et al. Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis. BMJ Open Diabetes Res Care. 2019; 7:e000723.

19. Allen NA, Zagarins SE, Feinberg RG, Welch G. Treating psychological insulin resistance in type 2 diabetes. J Clin Transl Endocrinol. 2016; 7:1–6.